Correlation of Pneumonia Score with Electronic Nose Signature: A Prospective Study

2005 ◽  
Vol 114 (7) ◽  
pp. 504-508 ◽  
Author(s):  
Neil G. Hockstein ◽  
Erica R. Thaler ◽  
Yuanqing Lin ◽  
D. Daniel Lee ◽  
C. William Hanson

Objectives: Ventilator-associated pneumonia (VAP) is a frequent complication in patients in surgical intensive care units. Pneumonia scores, chest radiography, and bronchoscopy are all employed, but there is no gold standard test for the diagnosis of VAP. The electronic nose, a sensor of volatile molecules, is well suited to testing the breath of mechanically ventilated patients. Our objective was to determine the potential use of an electronic nose as a diagnostic adjunct in the detection of VAP. Methods: We performed a prospective study of mechanically ventilated patients in a surgical intensive care unit. Clinical data, including temperature, white blood cell count, character and quantity of tracheal secretions, ratio of partial pressure of arterial oxygen to fraction of inspired oxygen, and chest radiographs, were collected, and a pneumonia score between 0 and 10 was calculated. Exhaled gas was sampled from the expiratory limb of the ventilator circuit. The gases were assayed with a commercially available electronic nose. Multidimensional data reduction analysis was used to analyze the results. Results: Forty-four patients were studied. Fifteen patients had pneumonia scores of 7 or greater, and 29 patients had scores of 6 or less. With Fisher discriminant analysis and K—nearest neighbor analysis, the electronic nose was able to discriminate between the two groups. Conclusions: The electronic nose is a new technology that is inexpensive, noninvasive, and portable. We demonstrate its ability to predict pneumonia, based on a well-recognized scoring system. This technology promises to serve as a diagnostic adjunct in the management of VAP.

2004 ◽  
Vol 199 (3) ◽  
pp. 75-76 ◽  
Author(s):  
Elliott R. Haut ◽  
Vicente H. Gracias ◽  
Corinna P. Sicoutris ◽  
Denise M. Meredith ◽  
Patrick M. Reilly ◽  
...  

2008 ◽  
Vol 34 (11) ◽  
pp. 1991-1998 ◽  
Author(s):  
Jean-Pierre Frat ◽  
◽  
Valérie Gissot ◽  
Stéphanie Ragot ◽  
Arnaud Desachy ◽  
...  

2018 ◽  
Vol 62 (10) ◽  
pp. 1443-1451 ◽  
Author(s):  
O. L. Schjørring ◽  
A. P. Toft‐Petersen ◽  
K. H. Kusk ◽  
P. Mouncey ◽  
E. E. Sørensen ◽  
...  

2017 ◽  
Vol 34 (8) ◽  
pp. 646-651 ◽  
Author(s):  
Jessica L. Buchheit ◽  
Daniel Dante Yeh ◽  
Matthias Eikermann ◽  
Hsin Lin

Background: Ketamine at subanesthetic doses has been shown to provide analgesic effects without causing respiratory depression and may be a viable option in mechanically ventilated patients to assist with extubation. The aim of this study was to evaluate the effects of low-dose ketamine on opioid consumption in mechanically ventilated adult surgical intensive care unit (ICU) patients. Methods: A retrospective review of mechanically ventilated adult patients receiving low-dose ketamine continuous infusion (1-5 µcg/kg/min) for adjunctive pain control admitted to surgical ICUs was conducted. Patients were included if they met an ICU safety screen for a spontaneous breathing trial (SBT) implying extubation readiness pending SBT results. The primary end point was the slope of change in morphine equivalents (MEs) 12 hours pre- and postketamine infusion. We hypothesized that low-dose ketamine would increase the slope of opioid dose reduction. Results: Forty patients were analyzed. The median dose of ketamine was 5 µg/kg/min (interquartile range [IQR]: 3.5-5) and the treatment duration was 1.89 days (IQR: 0.96-3.06). Prior to ketamine, the majority of patients received volume-controlled or pressure-supported ventilation with a median duration of 2.05 days (IQR: 1.38-3.61). The median time from the initiation of ketamine to extubation was 1.44 days (IQR: 0.58-2.66). For the primary outcome, there was a significant difference in the slope of ME changes from 1 to −0.265 mg/h 12 hours pre- and postketamine initiation ( P < .001). For the secondary outcomes, ketamine was associated with a decrease in vasopressor requirements (phenylephrine equivalent 70 vs 40 mg/h; P = .019). Conclusion: Low-dose continuous infusion ketamine in mechanically ventilated adult patients was associated with a significant increase in the rate of opioid dose reduction without adverse effects on hemodynamic stability.


Sign in / Sign up

Export Citation Format

Share Document